9.55
price up icon4.37%   0.40
after-market Handel nachbörslich: 9.70 0.15 +1.57%
loading

Replimune Group Inc Aktie (REPL) Neueste Nachrichten

pulisher
Jun 17, 2025

GAMMA Investing LLC Boosts Stock Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Jun 17, 2025
pulisher
Jun 14, 2025

Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Bank of America Corp DE - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

California State Teachers Retirement System Boosts Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 15,402 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Cuts Stock Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 07, 2025
pulisher
Jun 06, 2025

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | REPL Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Replimune Group, Inc. Grants Inducement Equity Awards to New Employees Under 2025 Plan - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

Replimune Group, Inc. (REPL) Stock Analysis: A Biotech Gem with 124% Potential Upside - DirectorsTalk Interviews

Jun 06, 2025
pulisher
Jun 03, 2025

JPMorgan reiterates overweight rating on Replimune stock after ASCO By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Replimune Group (NASDAQ:REPL) Price Target Raised to $22.00 at Piper Sandler - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Piper Sandler raises Replimune stock price target after updates By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Piper Sandler raises Replimune stock price target after updates - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

Does Replimune Group Inc (NASDAQ: REPL) Still Need To Convince Analysts? - Stocksregister

Jun 02, 2025
pulisher
Jun 02, 2025

Replimune Group (REPL) Price Target Raised by Piper Sandler Anal - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Replimune Group (REPL) Price Target Raised by Piper Sandler Analyst | REPL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Replimune (REPL) Price Target Raised by Piper Sandler Amid Positive Developments | REPL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Trims Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Replimune (REPL) Highlights Promising RP1 Data at ASCO 2025 | REPL Stock News - GuruFocus

Jun 01, 2025
pulisher
Jun 01, 2025

Replimune Presents New Analyses from the IGNYTE Study of RP1 plu - GuruFocus

Jun 01, 2025
pulisher
Jun 01, 2025

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting | REPL Stock News - GuruFocus

Jun 01, 2025
pulisher
Jun 01, 2025

Replimune Reports Promising Clinical Data for RP1 Plus Nivolumab at ASCO 2025, Highlighting Robust Responses and Safety Profile - Nasdaq

Jun 01, 2025
pulisher
Jun 01, 2025

Replimune Presents New Analyses From The IGNYTE Study Of RP1 Plus Nivolumab In Anti-PD1 Failed Melanoma At The 2025 American Society Of Clinical Oncology (ASCO) Annual Meeting - marketscreener.com

Jun 01, 2025
pulisher
Jun 01, 2025

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed ... - Enidnews.com

Jun 01, 2025
pulisher
Jun 01, 2025

Replimune's RP1 Achieves 33% Response Rate in Anti-PD1 Failed Melanoma Trial | REPL Stock News - Stock Titan

Jun 01, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Grows Stock Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Replimune Group (NASDAQ:REPL) Trading Down 5.9% – Time to Sell? - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Rating of “Buy” from Analysts - Defense World

May 31, 2025
pulisher
May 29, 2025

Replimune to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025
pulisher
May 29, 2025

Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Nuveen Asset Management LLC - Defense World

May 29, 2025
pulisher
May 28, 2025

Why Okta Stock Plunged on Wednesday - The Globe and Mail

May 28, 2025
pulisher
May 26, 2025

HC Wainwright Estimates Replimune Group Q3 Earnings - Defense World

May 26, 2025
pulisher
May 26, 2025

Leerink Partnrs Estimates Replimune Group Q1 Earnings - Defense World

May 26, 2025
pulisher
May 24, 2025

Replimune’s SWOT analysis: biotech firm’s stock poised for growth amid FDA review - Investing.com India

May 24, 2025
pulisher
May 23, 2025

Replimune director sells $260,168 in common stock By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 23, 2025

Replimune Group, Inc. (NASDAQ:REPL) Q4 2025 Earnings Call Transcript - Insider Monkey

May 23, 2025
pulisher
May 23, 2025

Replimune (REPL) Plans Major Stock Sale with 25.1M Shares Offeri - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Replimune Group Inc Files For Offer & Resale Of 25.1 Million Shares Of Common Stock Offered By Selling StockholdersSEC Filing - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Replimune Group Inc Files For Mixed Shelf Of Up To $250 MillionSEC Filing - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Replimune (REPL) Announces $250 Million Securities Shelf Filing | REPL Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Replimune Group, Inc. (REPL) Stock Analysis: An Insight into a Biotech Gem with 141% Upside Potential - DirectorsTalk Interviews

May 23, 2025
pulisher
May 23, 2025

Replimune Group Inc (REPL) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... - Yahoo Finance

May 23, 2025
pulisher
May 23, 2025

Stock Traders Buy High Volume of Call Options on Replimune Group (NASDAQ:REPL) - Defense World

May 23, 2025
pulisher
May 23, 2025

Replimune Group Inc (REPL) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Replimune director sells $260,168 in common stock - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Replimune Group Advances Oncolytic Immunotherapy Pipeline - TipRanks

May 23, 2025
pulisher
May 22, 2025

Replimune’s chief commercial officer sells $30,179 in stock By Investing.com - Investing.com South Africa

May 22, 2025
pulisher
May 22, 2025

Replimune Group, Inc. SEC 10-K Report - TradingView

May 22, 2025
pulisher
May 22, 2025

REPLIMUNE GROUP Earnings Results: $REPL Reports Quarterly Earnings - Nasdaq

May 22, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):